1 | and strategic advice to | | | | | | | 7 | 0.30% |
2 | counsel and strategic advice | | | | | | | 5 | 0.21% |
3 | approach our people practice | | | | | | | 5 | 0.21% |
4 | strategic advice to companies | | | | | | | 5 | 0.21% |
5 | advice to companies on | | | | | | | 4 | 0.17% |
6 | about our approach our | | | | | | | 4 | 0.17% |
7 | our approach our people | | | | | | | 4 | 0.17% |
8 | our people practice areas | | | | | | | 4 | 0.17% |
9 | people practice areas our | | | | | | | 4 | 0.17% |
10 | practice areas our work | | | | | | | 4 | 0.17% |
11 | areas our work contact | | | | | | | 4 | 0.17% |
12 | home about our approach | | | | | | | 4 | 0.17% |
13 | provide counsel and strategic | | | | | | | 4 | 0.17% |
14 | t 888 lsl6789 m | | | | | | | 3 | 0.13% |
15 | interests as an avid | | | | | | | 2 | 0.09% |
16 | other interests as an | | | | | | | 2 | 0.09% |
17 | all phases of clinical | | | | | | | 2 | 0.09% |
18 | phases of clinical trials | | | | | | | 2 | 0.09% |
19 | serve as member of | | | | | | | 2 | 0.09% |
20 | 8416431 download bio × | | | | | | | 2 | 0.09% |
21 | agreements including all phases | | | | | | | 2 | 0.09% |
22 | including all phases of | | | | | | | 2 | 0.09% |
23 | marketing initiatives strategies programs | | | | | | | 2 | 0.09% |
24 | monitor speaker programs and | | | | | | | 2 | 0.09% |
25 | and monitor speaker programs | | | | | | | 2 | 0.09% |
26 | audit and monitor speaker | | | | | | | 2 | 0.09% |
27 | a wide range of | | | | | | | 2 | 0.09% |
28 | 888 lsl6789 m 908 | | | | | | | 2 | 0.09% |
29 | initiatives strategies programs and | | | | | | | 2 | 0.09% |
30 | areas of expertise commercial | | | | | | | 2 | 0.09% |
31 | 917 8416431 download bio | | | | | | | 2 | 0.09% |
32 | contact life science legal | | | | | | | 2 | 0.09% |
33 | 2463820 m 917 8416431 | | | | | | | 2 | 0.09% |
34 | teams on sales and | | | | | | | 2 | 0.09% |
35 | activities provide counsel and | | | | | | | 2 | 0.09% |
36 | m 917 8416431 download | | | | | | | 2 | 0.09% |
37 | contact information ehartsoughlifesciencelegalcom t | | | | | | | 2 | 0.09% |
38 | on product launches including | | | | | | | 1 | 0.04% |
39 | product launches including support | | | | | | | 1 | 0.04% |
40 | development agreements including all | | | | | | | 1 | 0.04% |